Abstract

Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension

Author(s): McElhiney Linda F

Issue: Jan/Feb 2021 - Volume 25, Number 1

Page(s): 24-28

Download in electronic PDF format for $75

Abstract

Pediatric patients are sensitive to bitter-tasting substances and often resist taking them orally; however, they do like sweet substances from birth through mid-adolescence. To improve compliance, compounding pharmacists need to consider the palatability of compounded medications in addition to stability, safety, and effectiveness. Metronidazole compounded oral suspension is commonly prepared with the benzoate ester because it does not have a bitter taste; however, it has been on backorder and unavailable for months. A palatable metronidazole compounded oral suspension needs to be developed using the metronidazole base in order to meet the treatment needs of pediatric patients and improve compliance during this shortage.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2021 Pg. 24-28	Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Author(s): McElhiney Linda F
Jul/Aug 2018 Pg. 320	Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 98-102	Compounding Pearls -- Wound Care: Base Selection Author(s): Riepl Mike
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 304-309	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 77-82	Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets Author(s): Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
Nov/Dec 2008 Pg. 558-564	Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Sep/Oct 2021 Pg. 396-400	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 46	Metronidazole Benzoate 400-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 214-217	Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy Author(s): Fellman Claire, Ray Jody, Jordan Dinah G, Hreish Viola
May/Jun 2015 Pg. 248-251	Stability of Metronidazole Suspensions Author(s): Donnelly Ronald F, Ying James
Jan/Feb 2023 Pg. 72-77	Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base Author(s): Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2022 Pg. 94-98	A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Author(s): Riepl Mike
Mar/Apr 2021 Pg. 169-175	Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Jan/Feb 2009 Pg. 6-12	Compounding for Pediatric Patients: Case Reports and Formulations Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 1999 Pg. 34-35	Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor Author(s): Mason Dave
Sep/Oct 2021 Pg. 431-439	Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
May/Jun 2016 Pg. 257-261	Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
May/Jun 2017 Pg. 205-211	Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea